Native albumin for targeted drug delivery

Expert Opinion on Drug Delivery

Volumn 7, Issue 8, 2010, Pages 915-925

  Neumann, Elena ^a   Frei, Eva ^b   Funk, Dorothee ^b   Becker, Matthias D ^c   Schrenk, Hans Hermann ^b   Mller Ladner, Ulf ^a   Fiehn, Christoph ^d  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c TRIEMLI HOSPITAL   (Switzerland)

^d Centre of Rheumatic Diseases   (Germany)

Author keywords

Albumin; Arthritis; Drug delivery; Human serum albumin; Inflammation; Tumor

Indexed keywords

ALBUMIN; ALPHA INTERFERON; AMINO ACID; CAMPTOTHECIN; CATHEPSIN B; CISPLATIN; CORTICOSTEROID; CYSTEINE; DOXORUBICIN; FATTY ACID; GLUTAMIC ACID; LYSINE; MATRIX METALLOPROTEINASE; METHOTREXATE; MITOMYCIN C; PACLITAXEL; PLASMIN; SCAVENGER RECEPTOR;

CARBOXY TERMINAL SEQUENCE; CARTILAGE; CELL CULTURE; DRUG DELIVERY SYSTEM; DUCHENNE MUSCULAR DYSTROPHY; ENDOCYTOSIS; EX VIVO STUDY; FIBROBLAST; HUMAN; HYDROLYSIS; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; KUPFFER CELL; LIVER FIBROSIS; LIVER TUMOR; LYSOSOME; MACROMOLECULE; MUSCULAR DYSTROPHY; NONHUMAN; PANCREAS SCINTISCANNING; PANNUS; PH; RETICULOENDOTHELIAL SYSTEM; REVIEW; RHEUMATOID ARTHRITIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; SYNOVIUM; SYSTEMATIC REVIEW; TUMOR GROWTH;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; FLUORESCENT DYES; HUMANS; METHOTREXATE; MICE; RATS; SERUM ALBUMIN;

EID: 77954879791     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.2010.498474     Document Type: Review

References (55)

1. Peters TJ. All about albumin. Biochemistry, genetics, and medical applications 1996. Academic Press, New York; 1996
2. Coussens LM, Werb Z. Inflammatory cells and cancer: think different J Exp Med 2001;193:F23-6
3. Levick JR. Permeability of rheumatoid and normal human synovium to specific plasma proteins. Arthritis Rheum 1981;24:1550-1560
4. Ballantyne FC, Fleck A, Dick WC. Albumin metabolism in rheumatoid arthritis. Ann Rheum Dis 1971;30:265-270
5. Niwa Y, Iio A, Niwa G, et al. Serum albumin metabolism in rheumatic diseases: relationship to corticosteroids and peptic ulcer. J Clin Lab Immunol 1990;31:11-16
6. Stehle G, Sinn H, Wunder A, et al. The loading rate determines tumor targeting properties of methotrexate-albumin conjugates in rats. Anticancer Drugs 1997;8:677-685
7. Kremer P, Wunder A, Sinn H, et al. Laser-induced fluorescence detection of malignant gliomas using fluorescein-labeled serum albumin: experimental and preliminary clinical results. Neurol Res 2000;22:481-489
8. Kang H, Alam MR, Dixit V, et al. Cellular delivery and biological activity of antisense oligonucleotides conjugated to a targeted protein carrier. Bioconjug Chem 2008;19:2182-2188
9. Temming K, Meyer DL, Zabinski R, et al. Improved efficacy of alphavbeta3-targeted albumin conjugates by conjugation of a novel auristatin derivative. Mol Pharm 2007;4:686-694
10. Dosio F, Arpicco S, Stella B, et al. Folate-mediated targeting of albumin conjugates of paclitaxel obtained through a heterogeneous phase system. Int J Pharm 2009;382:117-123
11. Melgert BN, Weert B, Schellekens H, et al. The pharmacokinetic and biological activity profile of dexamethasone targeted to sinusoidal endothelial and Kupffer cells. J Drug Target 2003;11:1-10
12. Melgert BN, Olinga P, Jack VK, et al. Dexamethasone coupled to albumin is selectively taken up by rat nonparenchymal liver cells and attenuates LPS-induced activation of hepatic cells. J Hepatol 2000;32:603-611
13. Maeda H, Wu J, Sawa T, et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000;65:271-284
14. Jain RK. Delivery of molecular and cellular medicine to solid tumors. J Control Release 1998;53:49-67
15. Chu BC, Fan CC, Howell SB. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells. J Natl Cancer Inst 1981;66:121-124
16. Kratz F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release 2008;132:171-183
17. Wunder A, Stehle G, Sinn H, et al. Enhanced albumin uptake by rat tumors. Int J Oncol 1997;11:497-507
18. Hartung G, Stehle G, Sinn H, et al. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society. Clin Cancer Res 1999;5:753-759
19. Weigand M, Hartung G, Roboz J, et al. Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone. Anticancer Drug Des 2001;16:227-237
20. Hartung G, Heeger T, Bertsch T, et al. Adaption and clinical evaluation of a homogenous enzyme multiplied immunoassay technique (EMIT) for drug monitoring of a methotrexate-albumin conjugate (MTX-HSA) in humans. Onkologie 2000;23:352-357
21. Fiehn C, Kratz F, Sass G, et al. Targeted drug delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis. Ann Rheum Dis 2008;67:1188-1191
22. Gradishar WJ. Albumin-bound paclitaxel: a next-generation taxane. Expert Opin Pharmacother 2006;7:1041-1053
23. EMEA. Available from: http://www.ema.europa.euhumandocs/ Humans/EPAR/abraxane/abraxane.htm
24. Schulte S. Use of albumin fusion technology to prolong the half-life of recombinant factor VIIa. Thromb Res 2008;122(Suppl 4):S14-19
25. Melder RJ, Osborn BL, Riccobene T, et al. Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice. Cancer Immunol Immunother 2005;54:535-547
26. Rustgi VK. Albinterferon alfa-2b, a novel fusion protein of human albumin and human interferon alfa-2b, for chronic hepatitis C. Curr Med Res Opin 2009;25:991-1002
27. Esmaeili F, Dinarvand R, Ghahremani MH, et al. Docetaxel-albumin conjugates: preparation, in vitro evaluation and biodistribution studies. J Pharm Sci 2009;98:2718-2730
28. Tanaka T, Shiramoto S, Miyashita M, et al. Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME). Int J Pharm 2004;277:39-61
29. Wosikowski K, Biedermann E, Rattel B, et al. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells. Clin Cancer Res 2003;9:1917-1926
30. Eschen N, Bauder-Wust U, Frei E, et al. Aminopterin-human serum albumin conjugate (AP-HSA): uptake and cytotoxic effects in tumor cell lines. Int J Clin Pharmacol Ther 2002;40:564-566
31. Burger AM, Hartung G, Stehle G, et al. Pre-clinical evaluation of a methotrexate-albumin conjugate (MTX-HSA) in human tumor xenografts in vivo. Int J Cancer 2001;92:718-724
32. Wunder A, Stehle G, Schrenk HH, et al. Antitumor activity of methotrexate-albumin conjugates in rats bearing a Walker-256 carcinoma. Int J Cancer 1998;76:884-890
33. Vis AN, van der Gaast A, van Rhijn BW, et al. A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy. Cancer Chemother Pharmacol 2002;49:342-345
34. Wolff D, Frei E, Hofmeister N, et al. Methotrexate-albumin and aminopterin-albumin effectively prevent experimental acute graft-versus-host disease. Transplantation 2006;82:527-533
35. Fiehn C, Muller-Ladner U, Gay S, et al. Albumin-coupled methotrexate (MTX-HSA) is a new anti-arthritic drug which acts synergistically to MTX. Rheumatology (Oxford) 2004;43:1097-1105
36. Wunder A, Muller-Ladner U, Stelzer EH, et al. Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis. J Immunol 2003;170:4793-4801
37. Fiehn C, Neumann E, Wunder A, et al. Methotrexate (MTX) and albumin coupled with MTX (MTX-HSA) suppress synovial fibroblast invasion and cartilage degradation in vivo. Ann Rheum Dis 2004;63:884-886
38. Kremer P, Hartung G, Bauder-Wust U, et al. Efficacy and tolerability of an aminopterin-albumin conjugate in tumor-bearing rats. Anticancer Drugs 2002;13:615-623
39. Garmann D, Warnecke A, Kalayda GV, et al. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells. J Control Release 2008;131:100-106
40. Schmid B, Chung DE, Warnecke A, et al. Albumin-binding prodrugs of camptothecin and doxorubicin with an Ala-Leu-Ala-Leu-linker that are cleaved by cathepsin B: synthesis and antitumor efficacy. Bioconjug Chem 2007;18:702-716
41. Schmid B, Warnecke A, Fichtner I, et al. Development of albumin-binding camptothecin prodrugs using a Peptide positional scanning library. Bioconjug Chem 2007;18:1786-1799
42. Unger C, Haring B, Medinger M, et al. Phase I and pharmacokinetic study of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin. Clin Cancer Res 2007;13:4858-4866
43. Wooley PH. Collagen-induced arthritis in the mouse. Methods Enzymol 1988;162:361-373
44. Neumann E, Judex M, Kullmann F, et al. Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway. Gene Ther 2002;9:1508-1519
45. Muller-Ladner U, Kriegsmann J, Franklin BN, et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996;149:1607-1615
46. Lefevre S, Knedla A, Tennie C, et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 2009;15:1414-1420
47. Kremer P, Mahmoudreza F, Ding R, et al. Intraoperative fluorescence staining of malignant brain tumors using 5-aminofluorescein-labeled albumin. Neurosurgery 2009;64:53-60; discussion 60-151
48. Chen K, Xie J, Chen X. RGD-human serum albumin conjugates as efficient tumor targeting probes. Mol Imaging 2009;8:65-73
49. Amthor H, Egelhof T, McKinnell I, et al. Albumin targeting of damaged muscle fibres in the mdx mouse can be monitored by MRI. Neuromuscul Disord 2004;14:791-796
50. Clorius JH, Sinn H, Manke HG, et al. Serum albumin (SA) accumulation by bronchogenic tumours: a tracer technique may help with patient selection for SA-delivered chemotherapy. Eur J Nucl Med 1995;22:989-996
51. Becker MD, Nobiling R, Planck SR, Rosenbaum JT. Digital video-imaging of leukocyte migration in the iris: intravital microscopy in a physiological model during the onset of endotoxin-induced uveitis. J Immunol Methods 2000;240:23-37
52. Simi CK, Abraham TE. Nanocomposite based on modified TiO2-BSA for functional applications. Colloids Surf B Biointerfaces 2009;71:319-324
53. Tracey BM, Shuker DE. Characterization of azo coupling adducts of benzenediazonium ions with aromatic amino acids in peptides and proteins. Chem Res Toxicol 1997;10:1378-1386
54. Hanstein WG, Hatefi Y, Kiefer H. Radiochemical synthesis and photochemical properties of the uncoupler 2-azido-4-nitrophenol, a versatile photoaffinity labeling reagent. Biochemistry 1979;18:1019-1025
55. Murtaza Z, Herman P, Lakowicz JR. Synthesis and spectral characterization of a long-lifetime osmium (II) metal-ligand complex: a conjugatable red dye for applications in biophysics. Biophys Chem 1999;80:143-151